1. Liu, Shenhe, Ma, Xiaoya, Wang, Zichen, Fu, Tong, Deng, Tingxian. 2023. MAEL gene contributes to bovine testicular development through the m5C-mediated splicing. In iScience, 26, 105941. doi:10.1016/j.isci.2023.105941. https://pubmed.ncbi.nlm.nih.gov/36711243/
2. Chen, Xuemei, Wen, Feiqiu, Li, Zhu, Zou, Chang, Liu, Tao. 2022. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL. In Cancer medicine, 11, 3479-3490. doi:10.1002/cam4.4712. https://pubmed.ncbi.nlm.nih.gov/35488386/
3. Zhang, Xing, Ning, Yichong, Xiao, Yuzhong, Jiang, Dejian, Zhou, Jianlin. 2017. MAEL contributes to gastric cancer progression by promoting ILKAP degradation. In Oncotarget, 8, 113331-113344. doi:10.18632/oncotarget.22970. https://pubmed.ncbi.nlm.nih.gov/29371914/
4. Stallmeyer, Birgit, Bühlmann, Clara, Stakaitis, Rytis, O'Carroll, Dónal, Tüttelmann, Frank. 2024. Inherited defects of piRNA biogenesis cause transposon de-repression, impaired spermatogenesis, and human male infertility. In Nature communications, 15, 6637. doi:10.1038/s41467-024-50930-9. https://pubmed.ncbi.nlm.nih.gov/39122675/
5. Abbaszadegan, Mohammad Reza, Taghehchian, Negin, Aarabi, Azadeh, Saburi, Ehsan, Moghbeli, Meysam. 2021. MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma. In Diagnostic pathology, 16, 36. doi:10.1186/s13000-021-01098-z. https://pubmed.ncbi.nlm.nih.gov/33902648/
6. Shi, Chaoran, Kwong, Dora Lai-Wan, Li, Xue, Guan, Xin-Yuan, Li, Shan-Shan. 2022. MAEL Augments Cancer Stemness Properties and Resistance to Sorafenib in Hepatocellular Carcinoma through the PTGS2/AKT/STAT3 Axis. In Cancers, 14, . doi:10.3390/cancers14122880. https://pubmed.ncbi.nlm.nih.gov/35740546/
7. Cheng, Yu-Sheng, Wee, Shi-Kae, Lin, Tsung-Yen, Lin, Yung-Ming. . MAEL promoter hypermethylation is associated with de-repression of LINE-1 in human hypospermatogenesis. In Human reproduction (Oxford, England), 32, 2373-2381. doi:10.1093/humrep/dex329. https://pubmed.ncbi.nlm.nih.gov/29095993/
8. Tao, Jin, Cui, Jinshan, Xu, Yu, Cai, Shangli, Zhang, Xuepei. 2024. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis. In Aging, 16, 2090-2122. doi:10.18632/aging.205470. https://pubmed.ncbi.nlm.nih.gov/38301040/
智鼠故事 
